Neotract, maker of devices used to treat urological and gynecological disorders, has raised $23.73 million of a targeted $25.2 million second round of funding according to PE Hub. Based in Pleasanton, Calif., the company was backed in this round by Johnson & Johnson Development Corp. and New Enterprise Associates.